• 1
    Pele M, Tiret L, Kessler J-L, et al. SINE exonic insertion in the PTPLA gene leads to multiple splicing defects and segregates with the autosomal recessive centronuclear myopathy in dogs. Hum Mol Genet 2005;14:14171427.
  • 2
    Lee AF, Bowen JM. Evaluation of motor nerve conduction velocity in the dog. Am J Vet Res 1970;31:13611366.
  • 3
    Dubowitz V, Sewry CA. Histological and histochemical stains and reactions. In: Dubowitz V, Sewry CA, ed. Muscle Biopsy: A Practical Approach, 3rd ed. London: Saunders Elsevier; 2007:2139.
  • 4
    Zi-Fang L, Wu X, Jiang Y, et al. Non-pathogenic protein aggregates in skeletal muscle in MLF1 transgenic mice. J Neurol Sci 2008;264:7786.
  • 5
    Jaegger G, Marcellin-Little DJ, Levine D. Reliability of goniometry in Labrador Retrievers. Am J Vet Res 2002;63:979986.
  • 6
    Bönneman CG. The collagen VI-related myopathies: Muscle meets its matrix. Nat Rev Neurol 2011;7:379390.
  • 7
    Voit T, Tome FM. The congenital muscular dystrophies. In: Engel AG, Franzini-Armstrong C, eds. Myology, Basic and Clinical, 3rd ed. New York, NY: McGraw-Hill; 2004:1230.
  • 8
    Quijano-Roy S, Renault F, Romero N, et al. EMG and nerve conduction studies in children with congenital muscle dystrophy. Muscle Nerve 2004;29:292299.
  • 9
    Dubowitz V, Sewry CA. Congenital myopathies. In: Dubowitz V, Sewry CA, ed. Muscle Biopsy: A Practical Approach, 3rd ed. London: Saunders Elsevier; 2007:407442.
  • 10
    Kuo HJ, Maslen CL, Keene DR, et al. Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J Biol Chem 1997;272:2652226529.
  • 11
    Ishikawa H, Sugie K, Murayama K, et al. Ullrich disease: Collagen VI deficiency: EM suggests a new basis for muscular weakness. Neurology 2002;59:920923.
  • 12
    Ishikawa H, Sugie K, Murayama K, et al. Ullrich disease due to deficiency of collagen VI in the sarcolemma. Neurology 2004;62:620623.
  • 13
    Kawahara G, Okada M, Morone N, et al. Reduced cell anchorage may cause sarcolemma-specific collagen VI deficiency in Ullrich disease. Neurology 2007;69:10431049.
  • 14
    Bonaldo P, Braghetta P, Zanetti M, et al. Collagen VI deficiency induces early onset myopathy in the mouse: An animal model for Bethlem myopathy. Hum Mol Genet 1998;7:21352140.
  • 15
    Allamand V, Briñas L, Richard P, et al. ColVI myopathies: Where do we stand, where do we go? Skelet Muscle 2011;1:30.
  • 16
    Telfer WR, Busta AS, Bonnemann CG, et al. Zebrafish models of collagen VI-related myopathies. Hum Mol Genet 2010;19:24332444.
  • 17
    Merlini L, Angelin A, Tiepolo T, et al. Cyclosporin A corrects mitochondrial dysfunction and muscle apoptosis in patients with collagen VI myopathies. Proc Natl Acad Sci USA 2008;105:52255229.
  • 18
    Merlini L, Sabatelli P, Armaroli A, et al. Cyclosporine A in Ullrich congenital muscular dystrophy: Long-term results. Oxid Med Cell Longev 2011;2011:139194.
  • 19
    Muñana KR, Zhang D, Patterson EE. Placebo effect in canine epilepsy trials. J Vet Intern Med 2010;24:166170.
  • 20
    Fenichel GM, Griggs RC, Kissel J, et al. A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy. Neurology 2001;56:10751079.
  • 21
    Shelton GD, Engvall E. Canine and feline models of human inherited muscle diseases. Neuromuscul Disord 2005;15:127138.